Constance
Germany
52
2013-02-26
52
2013-02-26
These are the the leading inventors for applications assigned to Nycomed GmbH:
Nycomed GmbH based in Constance, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Ciclesonide containing aqueous pharmaceutical composition
#2 | 2011-12-22 β Patent 8,163,299 granted on 2012-04-24Stabilized pharmaceutical product
#3 | 2011-10-20 β Patent 8,324,391 granted on 2012-12-04Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#4 | 2011-10-20 β Patent 8,318,944 granted on 2012-11-27Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#5 | 2011-08-02 β Patent 7,988,999 granted on 2011-08-02Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
#6 | 2011-03-17 β Patent 8,288,445 granted on 2012-10-16Stable pharmaceutical products
#7 | 2010-09-30 β Patent 8,029,811 granted on 2011-10-04Stabilized pharmaceutical product
#8 | 2010-09-14 β Patent 7,794,752 granted on 2010-09-14Preparation and administration form comprising an acid-labile active compound
#9 | 2010-07-29 β Patent 8,354,535 granted on 2013-01-15Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
#10 | 2010-07-15 β Patent 8,278,300 granted on 2012-10-02Use for PDE5 inhibitors
#11 | 2010-05-13 β Patent 8,304,436 granted on 2012-11-06Pyrazolone derivatives as PDE4 inhibitors
#12 | 2010-02-11 β Patent 8,329,906 granted on 2012-12-11Guanidinyl-substituted hydroxy-6-phenylphenanthridines
#13 | 2009-12-08 β Patent 7,629,361 granted on 2009-12-08Salt of (S)-pantoprazole and its hydrates
#14 | 2009-09-24 β Patent 8,324,404 granted on 2012-12-043-thia-10-aza-phenanthrene derivatives
#15 | 2009-07-02 β Patent 8,202,880 granted on 2012-06-193-hydroxy-6-phenylphenanthridines as PDE4 inhibitors
#16 | 2009-05-21 β Patent 7,820,669 granted on 2010-10-262-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
#17 | 2009-05-21 β Patent 7,790,710 granted on 2010-09-07Imidazopyridine derivatives useful as iNOS inhibitors
#18 | 2009-01-29 β Patent 8,198,295 granted on 2012-06-12Benzonaphthyridines
#19 | 2009-01-01 β Patent 7,851,472 granted on 2010-12-14Triazolophthalazines
#20 | 2008-12-25 β Patent 7,632,844 granted on 2009-12-152-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
#21 | 2008-12-18 β Patent 8,106,047 granted on 2012-01-31Triazolophthalazines
#22 | 2008-11-13 β Patent 7,671,050 granted on 2010-03-02Triazolophthalazines
#23 | 2008-10-16 β Patent 8,242,146 granted on 2012-08-14Combination of a NSAID and a PDE-4 inhibitor
#24 | 2008-09-04 β Patent 8,017,633 granted on 2011-09-13Roflumilast for the treatment of diabetes mellitus
#25 | 2008-08-14 β Patent 7,718,668 granted on 2010-05-18Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
#26 | 2008-07-10 β Patent 8,003,798 granted on 2011-08-23Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#27 | 2008-06-19 β Patent 7,601,737 granted on 2009-10-13Isotopically substituted proton pump inhibitors
#28 | 2008-04-15 β Patent 7,357,943 granted on 2008-04-15Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
#29 | 2008-04-01 β Patent 7,351,723 granted on 2008-04-01Freeze-dried pantoprazole preparation and pantoprazole injection
#30 | 2008-03-20 β Patent 7,785,630 granted on 2010-08-31Preparation and administration form comprising an acid-labile active compound
#31 | 2007-12-27 β Patent 8,236,750 granted on 2012-08-07Composition comprising a pulmonary surfactant and a TNF-derived peptide
#32 | 2007-11-08 β Patent 7,838,521 granted on 2010-11-233-oxa-10-aza-phenanthrenes
#33 | 2007-08-09 β Patent 7,666,872 granted on 2010-02-23Use for PDE5 inhibitors
#34 | 2007-08-02 β Patent 7,494,990 granted on 2009-02-242-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
#35 | 2007-07-19 β Patent 7,585,872 granted on 2009-09-08Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors
#36 | 2007-07-19 β Patent 7,641,050 granted on 2010-01-05Medicine pack
#37 | 2007-05-31 β Patent 7,951,398 granted on 2011-05-31Pharmaceutical preparation comprising an active dispersed on a matrix
#38 | 2007-02-01 β Patent 8,371,292 granted on 2013-02-12Use of ciclesonide for the treatment of respiratory diseases
#39 | 2006-12-28 β Patent 7,279,488 granted on 2007-10-09Imidazopyridine-derivatives as inducible no-synthase inhibitors
#40 | 2006-12-14 β Patent 7,776,893 granted on 2010-08-17Use of PDE4 inhibitors for the treatment of diabetes mellitus
#41 | 2006-11-23 β Patent 7,402,321 granted on 2008-07-22Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
#42 | 2006-07-27 β Patent 7,470,704 granted on 2008-12-30Benzonaphthyridines
#43 | 2006-07-27 β Patent 8,182,824 granted on 2012-05-22Ciclesonide-containing sterile aqueous suspension
#44 | 2006-07-06 β Patent 7,736,673 granted on 2010-06-15Stabilized pharmaceutical product
#45 | 2006-06-15 β Patent 7,790,198 granted on 2010-09-07Preparation and administration form comprising an acid-labile active compound
#46 | 2006-05-18 β Patent 7,947,744 granted on 2011-05-24Stable pharmaceutical products
#47 | 2006-02-02 β Patent 7,879,833 granted on 2011-02-01Combination medicament
#48 | 2005-12-29 β Patent 7,452,998 granted on 2008-11-18Process for preparing optically pure active compounds
#49 | 2005-10-27 β Patent 7,423,046 granted on 2008-09-093-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
#50 | 2005-10-27 β Patent 7,329,676 granted on 2008-02-122-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
#51 | 2005-07-21 β Patent 7,951,397 granted on 2011-05-31Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
#52 | 2005-04-14 β Patent 7,468,433 granted on 2008-12-23Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
Also check out Nycomed GmbH's (Constance, Germany) applicant profile with 1 patent applications submitted.
399720 β